Doozio Posted - 1 week ago

$KROS INTA ⏰🧠♾️

FlynancialAnalyst Posted - 1 week ago

$KROS $2.75B mc $XBI #HiddenGem (just 233 watchers on Stocktwits) seeing accumulation off a fresh gold-cross above freshly rising 80 wk SMA Pct of all funds long shares is at record highs & rising Short float % is rolling over from 10% highs of year #SqueezeIt .. cc @doozio @RonIsWrong TrendEdge.app/asset/KROS

nastento Posted - 10/22/24

@ProDufferGolfer early enrollment completion is what I'm looking for. $KROS got it for their phase 2 so with thr only phase 3 occurring in PAH whe should complete enrollment early

Marketwizwallstreet Posted - 1 month ago

$ACET carl gordon @ orbimed sits on relatively few boards. $AVBP $KROS $TERN $CMPX and $ACET orbimed is arguably the best performing bio fund in 2024 Along with ra capital . They own 20% of adicet.

briefingcom Posted - 1 month ago

$KROS: Keros Therapeutics appoints Yung Chyung as Chief Medical Officer https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241016080612KROS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Quantumup Posted - 1 month ago

Piper Sandler⬆️PT $SRRK $42 was$28/OW, +⬆️apitegromab PoS=95% was $65%—conts2believe P3 SAPPHIRE data+P2 TOPAZ data, put $SRRK in good spot4reg subm in SMA pts ages 2 +—cont2model approval/launch=Q425—all 👀on $BHVN data—believes SMA mkt big enough2support multi anti-myostatin Tx's: $kros $lly $regn

Quantumup Posted - 1 month ago

BMO Capital raised the price target on Scholar Rock $SRRK to $38 was $34 and reiterated at an Outperform rating, plus increased the probability of Approval for apitegromab to 95% was 85%. BMO says, 'More Positive on SMA Post-SAPPHIRE; TP to $38:' "SRRK reported positive data for the Phase 3 SAPPHIRE trial for apitegromab in spinal muscular atrophy (SMA). We're increasing our probability of approval to 95% (from 85%) and updating our model to reflect the recent raise. The consistency of benefit for apitegromab in the exploratory cohort of patients (13-21) represented upside to our approval assumptions, and we see further upside from the OPAL trial in patients under two years, which SRRK plans to initiated mid-2025. We are reiterating OP with target price of $38 (from $34)." $bhvn $kros $lly $regn

Quantumup Posted - 1 month ago

Truist⬆️ $SRRK $36 was $20/Buy, after +VE data from $SRRK's Ph3 SMA trial. Truist says Tx is first anti-myostatin drug w/ +VE Ph3 data; positive read-through for Ph2 obesity (2Q25 readout)/also the broader myostatin space: $KROS Buy, $LLY Buy/ $REGN Buy. Also exposed is $BHVN NR:

CH_Expat Posted - 1 month ago

$KROS Me not buying in because I want them cheap.

vjtweet Posted - 09/24/24

$KROS good chance of taking off from here. No position yet.

vjtweet Posted - 2 months ago

$KROS a shakeout before next leg is an opportunity

Capitulation_0 Posted - 2 months ago

$BBIO $KROS breaking out.. $TARS breaking out. Even hated stocks like $TGTX, $AUPH getting bids. $BBIO probably has the biggest upside with best drug in a 15B market. All the stocks above, I or anyone had no idea why it was being sold off.

Thestocktraderhubzee Posted - 2 months ago

WATCHLIST SEP 13 2024. $FEAM Maxim Group Maintains Buy on 5E Advanced Materials, Lowers Price Target to $1.25 $GEV Evercore ISI Group Maintains Outperform on GE Vernova, Raises Price Target to $240 $ICCM HC Wainwright & Co. Reiterates Buy on Icecure Medical, Maintains $2.5 Price Target $MODG B of A Securities Maintains Neutral on Topgolf Callaway Brands, Lowers Price Target to $12 $KROS B of A Securities Maintains Buy on Keros Therapeutics, Lowers Price Target to $76

Stock_Titan Posted - 2 months ago

$KROS Keros Therapeutics Announces Updated Time of Presentation at 2024 Cantor Global Healthcare Conference https://www.stocktitan.net/news/KROS/keros-therapeutics-announces-updated-time-of-presentation-at-2024-icqo2eukp915.html

StockInvest_us Posted - 2 months ago

Signal alert: $KROS - PivotPoint bottom https://stockinvest.us/l/YNyOzMiabh

Pika_Capital Posted - 2 months ago

$KROS refresher

Monkey_Banana_Genius Posted - 2 months ago

@Pika_Capital $KROS

Monkey_Banana_Genius Posted - 2 months ago

$KROS verge of huge breakout

nastento Posted - 2 months ago

$GOSS interesting... $KROS phase 2 enrollment was completed early due to high demand. Will the same happen for seralutinib phase 3??? Would be very bullish news if so

briefingcom Posted - 2 months ago

$KROS: Keros Therapeutics announces update on enrollment in the phase 2 Tropos trial https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20240903081010KROS&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Stock_Titan Posted - 2 months ago

$KROS Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS Trial https://www.stocktitan.net/news/KROS/keros-therapeutics-announces-update-on-enrollment-in-the-phase-2-8nw5zvllwldi.html

insiderbuyingselling Posted - 3 months ago

$KROS new insider selling: 250000 shares. http://insiderbuyingselling.com/?t=KROS

DorianMD Posted - 3 months ago

$KROS why has this sold off the past few months?

CH_Expat Posted - 3 months ago

$KROS Very interested here, I would pull the trigger in the 30s. Trust @Pika_Capital big time, but we all know I like them cheap.

Stock_Titan Posted - 3 months ago

$KROS Keros Therapeutics Reports Second Quarter 2024 Financial Results https://www.stocktitan.net/news/KROS/keros-therapeutics-reports-second-quarter-2024-financial-waz4o31l6wj0.html

NVDAMillionaire Posted - 07/31/24

$KROS Keros Therapeutics, Inc. (NASDAQ:KROS): A Promising Biopharmaceutical Company Advancing Novel Therapies http://beyondspx.com/2024/07/29/keros-therapeutics-inc-nasdaqkros-a-promising-biopharmaceutical-company-advancing-novel-therapies/

Pika_Capital Posted - 07/23/24

$KROS reiterating my thesis. Whoever loaded in low $40s that's a very nice average.

vjtweet Posted - 07/23/24

$KROS Opened a decent position today.

Sowa5000 Posted - 4 months ago

$KROS Ready to run! 🏃‍♂️

Jayztrade Posted - 4 months ago

$KROS Picked up 100 today and I will hold for the big run coming.